BioDlink International Company Limited (SEHK: 1875)
Health Care · Biotechnology · CN
HK$4.02
+7.92% today · +77.9% 1Y
BioDlink International Company Limited (SEHK: 1875) operates in the Biotechnology industry within the Health Care sector. The company is valued at $396.25M and employs 596 people.
Over the last twelve months the share price has gained 77.9%, trading between 1.70 and 5.87.
Tweenvest scores BioDlink International Company Limited across four factors: quality 59/100, value 62/100, growth 100/100. Its strongest factor is growth.
1875 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $396.25M
- Revenue (TTM)
- $74.27M
- P/E
- —
- EPS
- -0.18
- Dividend yield
- —
- Beta (5Y)
- -0.13
- 52-week high
- HK$5.87
- 52-week low
- HK$1.70
- Avg volume (3M)
- —
- Shares outstanding
- 772.79M
- Employees
- 596
- Next earnings
- —
About BioDlink International Company Limited
BioDlink International Co., Ltd. operates as a clinical-stage biopharmaceutical firm, dedicating its resources to the development and future commercialization of novel oncology drugs and therapeutic solutions. Its pipeline features several key product candidates, including TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009, and its primary base of operations is situated in Suzhou, China.
- ISIN
- HK0000545266
- Founded
- 2009
- Listed since
- Nov 8, 2019
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €894.20 | +1.71% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.